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1. Introduction 
Ultraviolet spectroscopy has been widely used to 
study metal binding to transferrins [l-8] . The 
observed difference spectra are usually interpreted 
in terms of changes in ionization of tyrosyl residue, 
although earlier work suggested perturbation [5] or 
direct involvement [3,9] of tryptophan in Fe(II1) 
and Cu(I1) binding to transferrins. But Fe- and Cu- 
transferrins have broad charge-transfer absorption 
bands in the near ultraviolet [5,10,1 l] which extend 
into the wavelength region in which the tyrosine and 
tryptophan chromophores absorb. This makes inter- 
pretation difficult. Difference spectra obtained at 
pH 11 .O have been used to correct for this back- 
ground absorption of Fe-transferrins [2,4]. But, 
ionization of tyrosines may not be complete at pH 
1 I .O [l] and time-dependent exposure of ‘buried 
chromophores at alkaline pH [ 121 and alkaline 
hydrolysis of disulfide bonds [ 131 may further com- 
plicate determination of background absorption by 
this method. 
Colorless transferrin metal complexes appear to 
be more suitable for difference spectral studies. Zn(I1) 
[4,7] and trivalent lanthanides [6] give difference 
spectra which are similar to that for tyrosine ioniza- 
tion, with no apparent interfering absorption due to 
the metal ion. Ga(II1) binding to ovotransferrin has 
been reported [8,14] to give a difference spectrum 
characteristic of tyrosine ionization. A difference 
was noted between the spectrum of the first Ga 
bound and that of the second’ [8] . We have measured, 
(i) the difference spectra produced by Zn, Ga and 
Al(II1) binding to ovotransferrin and human serum 
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transferrin, and (ii) the change in difference spectra 
produced by the addition of Zn to Al- and Ga- 
transferrins. We found that, (i) binding of Zn to 
transferrins gives difference spectra which are consis- 
tent with tyrosine ionization but binding of Ga and 
Al produced difference spectra characteristic of 
perturbation of tryptophan and tyrosine, and (ii) 
addition of Zn transforms Al- and Ga-transferrin 
difference spectra into that for the Zn complex. Thus, 
Zn competes with Al and Ga for the same binding 
sites, but not necessarily for the same ligands. These 
results suggest hat tyrosine is not a ligand in Al and 
Ga binding to transferrins and that tryptophan is in 
or near the metal binding sites. 
2. Experimental 
Chicken ovotransferrin was purchased from Sigma 
Chemical Co. and purified on a CM-cellulose column 
[ 151. Human serum transferrin, purchased from 
Behring Diagnostics (Batch No. 1347 1 A), was used 
without further purification. The Cary 15 spectrophoto- 
meter was checked by the procedure of Mihalyi [ 161. 
There were no stray light effects up to an absorbance 
of 3.6 (K&rod solutions) and no fluorescence 
effects up to an absorbance of 2.0 (ovotransferrin 
solutions). Difference spectra were obtained at protein 
concentrations which gave an absorbance of less than 
1.2 (0.5 nm band width) at the peak of the lowest 
wavelength difference band. Protein concentrations 
were determined at 280 and 278 nm for apo-ovotrans- 
ferrin and apo-human serum transferrin, respectively, 
using an absorptivity of 85 800 liter mol-’ cm-’ for 
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both proteins. Concentrations (about 4 X 10s4 M 
metal ion) of stock metal solutions (ZnS04, Alz(S04)3 
and Ga2(S04)a in 10d3 N HCl) were determined by 
atomic absorption analyses. Difference spectra were 
obtained in 1 cm cells using the 0.1 absorbance scale, 
at a scan rate of 6 nm/min, after addition of micro- 
liter volumes of metal ion to the sample cell and the 
same volume of 10e3 N HCl to the reference cell. 
Data were corrected for dilution effects. Measurements 
made with tandem cells [ 171 gave similar results, so 
that for Zn-, Al- and Ga-transferrin, there is no 
absorption by complexes between metal and buffer. 
Complete titration curves (Ae versus metal added, 
data not shown) were used to establish that the dif- 
ference spectra presented were obtained at full satura- 
tion of the metal binding sites with Zn, Al and Ga. 
3. Results and discussion 
Difference spectra for tyrosine ionization and for 
perturbation of tyrosine and tryptophan are shown 
in fig.1. Difference spectra produced by Zn, Al and 
Ga binding to ovotransferrin and human serum trans- 
ferrin are shown in fig.2. The locations and absorptiv- 
X hl 
Fig.1. Ionization difference spectrum of N-acetyl tyrosine, pH 
11.3 versus pH 7.6 (A) and perturbation difference spectra 
produced by 20% (v/v) ethylene glycol for tyrosine (B) and 
tryptophan (C). 
X (nml 
Fig.2. Difference spectra produced by Zn(I1) (-), 
Al(II1) (- - -) and Ga(II1) ( . .) binding to ovotransferrin 
(OT) and human serum transferrin (HST). Experimental 
conditions: pH 8.4,0.025 M borate buffer containing 
01025 M KC1 and 5 X IO-’ M NaHCO, ; transferrin concen- 
trations between 5.6 and 6.4 X low6 M; and (Zn)/(OT) = 
2.64, (Al)/(OT) = 3.08, (Ga)/(OT) = 2.58, (Zn)/(HST) = 
2.45, (Al)/(HST) = 2.38, (Ga)/HST) = 2.34. 
ities of the more prominent difference bands are 
summarized in table 1. The shapes, locations of the 
difference bands, and the absorptivity ratio (Ae,/ 
Aer) of the shortest to the longest wavelength 
positive bands for the Zn-transferrins are similar to 
those for tyrosine ionization. However, small irregula- 
rities in the difference spectra between 275-287 nm, 
particularly for Zn-human serum transferrin, suggest 
that perturbation of tyrosine and tryptophan also 
occurs. The spectra for Al- and Ga-transferrins are 
distinctly different from Zn- . Positive bands appear 
at 287-291 nm, 281-282 nm and 237-241 nm and 
negative troughs appear at 305 nm and 2.52-257 nm. 
These appear to be characteristic of perturbation of 
tryptophan and of tyrosine, with the former readily 
300 
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Table 1 
December 1976 
Wavelength and molar absorptivities of the difference bands for tyrosine ionization, solvent perturbation of tyrosine 
and of tryptophan, and for metal binding to transferrins 
293 2067 242 10 175 4.9 273 - 218 
285 99 277 56 227.5 336 3.4 
290 278 282 181 0.65 225 2460 8.8 250 - 100 
Ovotransferrin 
Al 
Ga 
Zn 
291 2380 282 1510 0.63 238 19 380 8.1 252 -2010 305 -470 
290 1750 282 960 0.55 237 16 020 9.2 257 - 610 305 -280 
292 6090 283 2020 245 26 380 4.3 271 - 670 
Human serum transferrhr 
Al 287 2040 281 1300 0.64 238 15 080 7.4 252 -2840 305 -800 
Ga 288 1470 281 620 0.42 241 13 530 9.2 257 - 620 305 -700 
Zn 295 2940 287 1720 247 14 050 4.8 213 - 740 
aN-acetyl tyrosine ionization 
bTyrosine, 20% (v/v) ethylene glycol perturbation 
‘Tryptophan, 20% (v/v) ethylene glycol perturbation 
recognizable near 292-295 nm in the case of human 
serum transferrin. The absorptivity ratio Aes/Aer 
ranges from 7.4-9.2, similar to that observed for 
tryptophan perturbation (EM), and considerably 
larger than that observed for tyrosine ionization (4.9) 
or for perturbation of tyrosine (3.4). 
Zn displacement of Al from Al-ovotransferrin 
and of Ga from Ga-human serum transferrin is shown 
in iig.3. Similar results (not shown) were obtained for 
Zn displacement of Al in Al-human serum transferrin 
Fig.3. Zn(II) displacement of Al(III) in Al(III) ovotrans- 
ferrin (A) and of Ga(III) in Ga(III) human serum trans- 
ferrin (B). Experimental conditions: pH 8.4, 0.025 M borate 
buffer containing 0.025 M KCl and 5 X lo-’ M NaHCO,, 
transferrin concentration between 6.0 and 6.4 X 10m6 M and 
Metal(s) Curve 
Ma 
(Transferrin) 
GW 
(Transferrin) 
(NM (-1 2.80 - 
(A)Al, Zn (____) 2.80 1.32 
(A)Al, Zn . 2.80 2.64 
(WGa ;I?, 2.34 - 
(B)Ga, Zn (____) 2.34 1.22 
(B)Ga, Zn (. . .) 2.34 2.45 
a(M) is concentration of Al for (A) and of Ga for (B). 
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and Ga in Ga-ovotransferrin. Addition of less than 
saturating amounts of Zn resulted in difference spectra 
intermediate between that for the metal being displac- 
ed and that for Zn-transferrin. Addition of more 
than saturating amounts of Zn gave difference spectra 
for Zn-transferrin (compare fig.2), indicating 
compleie displacement of the original metal in the 
complex. These results indicate that Zn, Al and Ga 
occupy the same binding sites. 
The tryptophan perturbation produced by Al and 
Ga binding to transferrin could be due to solvent or 
charge effects [ 181. Perturbation difference spectra 
of proteins often show a negative trough near 300 nm, 
ascribed to the effects of nearby charged groups on 
tryptophyl residues [ 191. The binding of Al and Ga 
most likely increases the net positive charge at the 
binding site. But the sign of the absorption change 
near 290 nm is not consistent with introduction of 
positive charge near tryptophan [20]. Furthermore, 
the appearance of the negative trough at 305 nm and 
the Ae,/Ae, > 0.5 (table 1) suggest a solvent induced 
perturbation rather than a charge effect [21]. Accord- 
ingly, the difference bands are consistent with solvent 
perturbation (perhaps burial) of tryptophan. The 
Ae, for d-- and Ga-transferrins, 735-l 190 
(neglecting any perturbation of tyrosine and assuming 
perturbation of one tryptophan per metal atom 
bound to transferrin, table l), is at the high end of 
the range of values observed for tryptophan [21,22]. 
AE 1 for ‘burying’ a tryptophan is about 1600 [ 181, so 
that Al and Ga binding (possibly to carboxylates) 
may cause a crevice containing tryptophan to be 
closed. Chemical modification of tryptophan does 
not interfere with Fe binding to human serum trans- 
ferrins [23] , but this does not preclude tryptophan 
as a component of the binding sites. 
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